EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The Long-Term Safety of Topical Corticosteroids in Atopic Dermatitis: A Systematic Review

Jane Harvey iD, Stephanie J Lax iD, Alison Lowe, Miriam Santer, Sandra Lawton, Sinead M Langan, Amanda Roberts, Beth Stuart, Hywel C Williams, Kim S Thomas

Skin Health and Disease · 01.10.2023 · 3 (5)

DOI: 10.1002/ski2.268 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Skin Health and Disease, online erschienen am 16.08.2023. Verfasst von Jane Harvey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Evidence Based Dermatology School of Medicine University of Nottingham Nottingham UK. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research, National Institute for Health and Care Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Topical corticosteroids (TCS) are a first-line treatment for eczema, but there are concerns about their safety when used long-term.

Objectives

To systematically review adverse effects associated with longer-term use of TCS for eczema.

Methods

Randomised controlled trials (RCTs), cohort and case-control studies reporting adverse effects of TCS (comparators: no TCS treatment, other topicals) in patients with eczema were identified. Included studies had greater than one year of follow-up, minimum cohort size of 50 participants, or minimum 50 per arm for RCTs. Evidence was GRADE-assessed. Prospero registration CRD42021286413.

Results

We found seven studies (two randomised, five observational); two RCTs (n = 2570, including 1288 receiving TCS), two cohort (all received TCS n = 148) and three case-control studies (cases n = 10 322, controls n = 12 201). Evidence from two RCTS (n = 2570, children, three and five years' duration) comparing TCS to topical calcineurin inhibitors found intermittent TCS use probably results in little to no difference in risk of growth abnormalities, non-skin infections, impaired vaccine response and lymphoma/non lymphoma malignancies. The five-year RCT reported only one episode of skin atrophy (n = 1213 TCS arm; mild/moderate potency), suggesting TCS use probably results in little to no difference in skin thinning when used intermittently to treat flares. No cases of clinical adrenal insufficiency were reported in 75 patients using mild/moderate TCS in the three-year RCT. Small associations between TCS and type-2 diabetes and lymphoma were identified in two case-control studies compared to no TCS, but the evidence is very uncertain. No long-term studies concerning topical steroid withdrawal or eye problems were identified.

Conclusion

This review provides some reassuring data on growth and skin thinning when TCS are used intermittently for up to 5 years, but many knowledge gaps remain.

Autor:innen und Institutionen

  • Centre of Evidence Based Dermatology School of Medicine University of Nottingham Nottingham UK.
  • University Hospitals Sussex NHS Foundation Trust Worthing UK.
  • Primary Care Research Centre University of Southampton Southampton UK.
  • Department of Dermatology Rotherham NHS Foundation Trust Rotherham UK.
  • London School of Hygiene and Tropical Medicine London UK.
  • Nottingham Support Group for Carers of Children with Eczema Nottingham UK.

ORCID-Profile: Jane Harvey, Stephanie J Lax

Förderung

  • National Institute for Health Research
  • National Institute for Health and Care Research

Zitieren

APA

Harvey, J., Lax, S. J., Lowe, A., Santer, M., Lawton, S., Langan, S. M., Roberts, A., Stuart, B., Williams, H. C., & Thomas, K. S. (2023). The Long-Term Safety of Topical Corticosteroids in Atopic Dermatitis: A Systematic Review. Skin Health and Disease, 3(5). https://doi.org/10.1002/ski2.268

Vancouver

Harvey J, Lax SJ, Lowe A, Santer M, Lawton S, Langan SM, et al. The Long-Term Safety of Topical Corticosteroids in Atopic Dermatitis: A Systematic Review. Skin Health and Disease. 2023;3(5). doi:10.1002/ski2.268

BibTeX
@article{Harvey2023,
  author = {Harvey, Jane and Lax, Stephanie J and Lowe, Alison and Santer, Miriam and Lawton, Sandra and Langan, Sinead M and Roberts, Amanda and Stuart, Beth and Williams, Hywel C and Thomas, Kim S},
  title = {The Long-Term Safety of Topical Corticosteroids in Atopic Dermatitis: A Systematic Review},
  journal = {Skin Health and Disease},
  year = {2023},
  volume = {3},
  number = {5},
  doi = {10.1002/ski2.268}
}
Kostenlos starten →